Delcath Systems share price logo

Delcath Systems

NASDAQ: DCTH

Small Cap

$15.13

-0.28

(-1.82%)

as on

Delcath Systems Stock Performance

as on October 3, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $15.06
    $15.53
    downward going graph

    0.46%

    Downside

    2.64%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $8.12
    $17.42
    downward going graph

    46.33%

    Downside

    15.14%

    Upside

    downward going graph

Delcath Systems share price movements today

Previous Close
$15.41
Open
$15.42
Volume
361.8K
Market Cap
$534.7M
Day's Low - High
$15.06 - $15.53
52 Week Low - High
$8.12 - $17.42

Delcath Systems Historical Returns

1 Month Return
-8.19 %
3 Month Return
+ 14.62 %
1 Year Return
+ 36.31 %
3 Year Return
+ 314.52 %
5 Year Return
+ 54.39 %

Delcath Systems Stock Fundamentals & Key Indicators

Check Delcath Systems market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$534.7M

EPS (TTM)

0.0111

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

1398.34

Industry PE ratio

-7.81

PEG Ratio

-17.73

EBITDA

1.7M

Revenue (TTM)

95.4M

Profit Margin

87.05%

Return On Equity TTM

0.46%

Delcath Systems vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Delcath Systems with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$534.7M54.39%1398.3487.05%0.00%
Buy$49.1B-24.16%49.0577.98%0.00%
Buy$110.4B-32.15%21.1666.69%3.31%
StrongBuy$171.0B-16.82%31.3056.80%2.56%
StrongBuy$105.6B2.69%28.1065.17%1.29%

Stock Returns calculator for Delcath Systems Stock including INR - Dollar returns

The Delcath Systems stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 10Y

Delcath Systems investment value today

Current value as on today

₹1,47,952

Returns

₹47,952

(+47.95%)

Returns from Delcath Systems Stock

₹36,306 (+36.31%)

Dollar Impact

₹11,646 (+11.65%)

Analyst Recommendation on Delcath Systems Stock

Based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for Delcath Systems. Average target price of $24

Delcath Systems Share Price Target

Get share price movements and forecasts by analysts on Delcath Systems.

What analysts predicted

36.96%UPSIDE

Target Price

$24

Current Price

$15.13

Analyzed by

2 Analysts

High

$32

Target

$24.00

Low

$24

Delcath Systems target price $24, a slight upside of 36.96% compared to current price of $15.13. According to 2 analysts rating.

Indian Investors' Interest in Delcath Systems Stock

Search interest for Delcath Systems Stock has decreased by -47% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-47% versus previous 30 day period

Delcath Systems Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
3
7
11
15
19
24
20
20
24
29
Gross Profit
2
6
9
12
16
20
17
17
21
26
Operating Income
-10
-3
-1
3
0
2
0
-2
-1
2
EBITDA
-10
-13
1
10
1
3
0
-1
0
3
Interest Expense
0
0
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-11
-13
1
-3
1
3
0
-1
0
3
Income Tax Expense
-
-
-
-
0
0
0
0
0
0
Net Income
-11
-13
1
-3
1
2
0
-1
-1
2
Net Profit Margin
71.23%
80.44%
85.36%
85.92%
85.62%
86.26%
87.24%
85.48%
85.05%
89.75%

Delcath Systems Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Mar 2021
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
2
3
1
1
3
2
2
37
85
Gross Profit
2
2
0
1
2
2
1
31
73
Operating Income
-18
-27
-19
-21
-24
-33
-38
-12
0
EBITDA
-23
-10
-3
-23
-24
-33
-45
-26
3
Interest Expense
21
7
4
0
1
2
1
-
-
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-45
-19
-8
-24
-25
-36
-47
-26
3
Income Tax Expense
-
-
-
-
-
-
-
-
0
Net Income
-45
-19
-8
-24
-25
-36
-47
-26
2
Net Profit Margin
74.18%
70.38%
54.49%
61.12%
81.13%
74.77%
69.25%
83.37%
86.16%

Delcath Systems Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-11
-13
1
-3
1
2
0
-1
-1
2
Operating Cash Flow
-9
-4
-3
-1
2
7
4
8
0
5
Investing Cash Flow
4
10
0
-15
-25
0
0
0
0
0
Financing Cash Flow
4
-2
-2
40
3
14
3
-5
-2
0
Change in Cash
0
2
-6
24
-19
21
7
1
-2
6

Delcath Systems Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Mar 2021
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-45
-19
-8
-24
-25
-36
-47
-26
2
Operating Cash Flow
-15
-14
-23
-22
-22
-24
-31
-18
22
Investing Cash Flow
0
0
0
0
0
0
-19
0
-26
Financing Cash Flow
15
13
30
42
20
10
51
39
15
Change in Cash
0
-1
6
18
-1
-15
0
19
11

Global Institutional Holdings in Delcath Systems

Check out the Institutions with significant holdings in Delcath Systems.

Funds
Holdings
Vanguard
4.01%
VANGUARD INDEX FUNDS
3.73%
iShares
3.31%
Fidelity Salem Street Trust
0.94%
Fidelity Concord Street Trust
0.80%

Insights on Delcath Systems

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, DCTH stock has moved up by 57.1%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, DCTH has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, DCTH has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, -1.89M → 2.66M (in $), with an average increase of 108.7% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 20.56M → 29.13M (in $), with an average increase of 10.7% per quarter

About Delcath Systems

Delcath Systems, Inc. is an interventional oncology firm operating in the United States and Europe, dedicated to developing treatments for both primary and secondary liver cancers. Its leading investigational product is the HEPZATO KIT, a unique hepatic delivery system for melphalan that targets high-dose chemotherapy specifically to the liver. This innovative approach aims to substantially reduce systemic drug exposure and mitigate associated side effects. HEPZATO's clinical evaluation is advancing through the FOCUS trial, which is designed to assess the objective response rate in individuals with metastatic uveal melanoma whose disease is primarily concentrated in the liver. Furthermore, the company offers a separate version of HEPZATO as a medical device in Europe, marketed under the CHEMOSAT Hepatic Delivery System brand (or simply CHEMOSAT). This system empowers European medical centers to manage a diverse array of liver cancer conditions. Delcath Systems, Inc. was established in 1988, with its corporate headquarters situated in New York, New York.
OrganisationDelcath Systems
Headquarters566 Queensbury Avenue, Queensbury, NY, 12804, US
IndustryMedical - Devices
CEOGerard J. Michel

Key Management of Delcath Systems

Name

Title

Mr. Gerard J. Michel MBA, MS

CEO & Director

Dr. Martha S. Rook Ph.D.

Chief Operating Officer

Dr. Vojislav Vukovic M.D., M.Sc., Ph.D.

Chief Medical Officer

Ms. Sandra Pennell C.P.A.

Chief Financial Officer

Mr. David Hoffman J.D.

General Counsel, Corporate Secretary & Chief Compliance Officer

Dr. Johnny John M.D.

Senior Vice President of Clinical Operations & Medical Affairs

Mr. Kevin Muir

Chief Commercial Officer

Dr. Michael Brunner M.D.

Senior Vice President of Interventional Oncology

FAQs

What is Delcath Systems share price today?

Delcath Systems share price today is $15.13 as on at the close of the market. Delcath Systems share today touched a day high of $15.53 and a low of $15.06.

What is the 52 week high and 52 week low for Delcath Systems share?

Delcath Systems share touched a 52 week high of $17.42 on and a 52 week low of $8.12 on . Delcath Systems stock price today i.e. is closed at $15.13,which is 13.15% down from its 52 week high and 86.33% up from its 52 week low.

What is Delcath Systems's market capitalisation today?

Delcath Systems market capitalisation is $0.00T as on .

How to invest in Delcath Systems Stock (DCTH) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Delcath Systems on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Delcath Systems Stock (DCTH) from India?

Indian investors can start investing in Delcath Systems (DCTH) shares with as little as ₹96.300003051758 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹963.00 in Delcath Systems stock (as per the Rupee-Dollar exchange rate as on ). Based on Delcath Systems share’s latest price of $15.13 as on October 3, 2026 at 8:45 am IST, you will get 0.6609 shares of Delcath Systems. Learn more about fractional shares .

What are the returns that Delcath Systems has given to Indian investors in the last 5 years?

Delcath Systems stock has given 54.39% share price returns and 28.69% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?